TREMFYA One-Press Patient Controlled Injector Approved for Plaque Psoriasis

The Janssen Pharma, a part of Johnson & Johnson, won FDA approval for its TREMFYA One-Press single-dose injector. The device is used to deliver TREMFYA (guselkumab) as a treatment for moderate to severe plaque psoriasis.

The TREMFYA One-Press allows patients to decide how fast and with how much pressure to deliver the medication. This lets ev (Read more...)

Full Story →